AAAAAA
Results:
1-22
|
Results: 22
Authors:
Stoddart, CA
Liegler, TJ
Mammano, F
Linquist-Stepps, VD
Hayden, MS
Deeks, SG
Grant, RM
Clavel, F
McCune, JM
Citation: Ca. Stoddart et al., Impaired replication of protease inhibitor-resistant HIV-1 in human thymus, NAT MED, 7(6), 2001, pp. 712-718
Authors:
Napolitano, LA
Grant, RM
Deeks, SG
Schmidt, D
De Rosa, SC
Herzenberg, LA
Herndier, BG
Andersson, J
McCune, JM
Citation: La. Napolitano et al., Increased production of IL-7 accompanies HIV-l-mediated T-cell depletion: implications for T-cell homeostasis, NAT MED, 7(1), 2001, pp. 73-79
Authors:
Penn, ML
Myers, M
Eckstein, DA
Liegler, TJ
Hayden, M
Mammano, F
Clavel, F
Deeks, SG
Grant, RM
Goldsmith, MA
Citation: Ml. Penn et al., Primary and recombinant HIV type 1 strains resistant to protease inhibitors are pathogenic in mature human lymphoid tissues, AIDS RES H, 17(6), 2001, pp. 517-523
Authors:
Liegler, TJ
Hayden, MS
Lee, KH
Hoh, R
Deeks, SG
Grant, RM
Citation: Tj. Liegler et al., Protease inhibitor-resistant HIV-1 from patients with preserved CD4 cell counts is cytopathic in activated CD4 T lymphocytes, AIDS, 15(2), 2001, pp. 179-184
Authors:
Price, RW
Paxinos, EE
Grant, RM
Drews, B
Nilsson, A
Hoh, R
Hellmann, NS
Petropoulos, CJ
Deeks, SG
Citation: Rw. Price et al., Cerebrospinal fluid response to structured treatment interruption after virological failure, AIDS, 15(10), 2001, pp. 1251-1259
Authors:
Deeks, SG
Wrin, T
Liegler, T
Hoh, R
Hayden, M
Barbour, JD
Hellmann, NS
Petropoulos, CJ
McCune, JM
Hellerstein, MK
Grant, RM
Citation: Sg. Deeks et al., Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia., N ENG J MED, 344(7), 2001, pp. 472-480
Authors:
Grant, RM
Citation: Rm. Grant, Rethinking "Gnosticism": An argument for dismantling a dubious category, J RELIG, 81(4), 2001, pp. 645-647
Authors:
Roland, ME
Martin, JN
Grant, RM
Hellmann, NS
Bamberger, JD
Katz, MH
Chesney, M
Franses, K
Coates, TJ
Kahn, JO
Citation: Me. Roland et al., Postexposure prophylaxis for human immunodeficiency virus infection after sexual or injection drug use exposure: Identification and characterization of the source of exposure, J INFEC DIS, 184(12), 2001, pp. 1608-1612
Authors:
Celum, CL
Buchbinder, SP
Donnell, D
Douglas, JM
Mayer, K
Koblin, B
Marmor, M
Bozeman, S
Grant, RM
Flores, J
Sheppard, HW
Citation: Cl. Celum et al., Early human immunodeficiency virus (HIV) infection in the HIV network for prevention trials vaccine preparedness cohort: Risk behaviors, symptoms, and early plasma and genital tract virus load, J INFEC DIS, 183(1), 2001, pp. 23-35
Authors:
Grant, RM
Citation: Rm. Grant, Theophilus of Antioch. The life and thought of a second-century bishop, CATH HIST R, 87(2), 2001, pp. 309-310
Authors:
Huang, SS
Barbour, JD
Deeks, SG
Huang, JS
Grant, RM
Ng, VL
McCune, JM
Citation: Ss. Huang et al., Reversal of human immunodeficiency virus type 1 - Associated hematosuppression by effective antiretroviral therapy, CLIN INF D, 30(3), 2000, pp. 504-510
Authors:
Parkin, NT
Deeks, SG
Wrin, MT
Yap, J
Grant, RM
Lee, KH
Heeren, D
Hellmann, NS
Petropoulos, CJ
Citation: Nt. Parkin et al., Loss of antiretroviral drug susceptibility at low viral load during early virological failure in treatment-experienced patients, AIDS, 14(18), 2000, pp. 2877-2887
Authors:
Blower, SM
Gershengorn, HB
Grant, RM
Citation: Sm. Blower et al., A tale of two futures: HIV and antiretroviral therapy in San Francisco, SCIENCE, 287(5453), 2000, pp. 650-654
Authors:
Schramm, B
Penn, ML
Palacios, EH
Grant, RM
Kirchhoff, F
Goldsmith, MA
Citation: B. Schramm et al., Cytopathicity of human immunodeficiency virus type 2 (HIV-2) in human lymphoid tissue is coreceptor dependent and comparable to that of HIV-1, J VIROLOGY, 74(20), 2000, pp. 9594-9600
Authors:
Deeks, SG
Barbour, JD
Martin, JN
Swanson, MS
Grant, RM
Citation: Sg. Deeks et al., Sustained CD4(+) T cell response after virologic failure of protease inhibitor-based regimens in patients with human immunodeficiency virus infection, J INFEC DIS, 181(3), 2000, pp. 946-953
Authors:
Greenblatt, RM
Ameli, N
Grant, RM
Bacchetti, P
Taylor, RN
Citation: Rm. Greenblatt et al., Impact of the ovulatory cycle on virologic and immunologic markers in HIV-infected women, J INFEC DIS, 181(1), 2000, pp. 82-90
Authors:
Deeks, SG
Grant, RM
Citation: Sg. Deeks et Rm. Grant, Sustained CD4 responses after virological failure of protease inhibitor-containing therapy, ANTIVIR TH, 4, 1999, pp. 7-11
Authors:
Locher, CP
Grant, RM
Collisson, EA
Reyes-Teran, G
Elbeik, T
Kahn, JO
Levy, JA
Citation: Cp. Locher et al., Antibody and cellular immune responses in breakthrough infection subjects after HIV type 1 glycoprotein 120 vaccination, AIDS RES H, 15(18), 1999, pp. 1685-1689
Authors:
Staprans, S
Marlowe, N
Glidden, D
Novakovic-Agopian, T
Grant, RM
Heyes, M
Aweeka, F
Deeks, S
Price, RW
Citation: S. Staprans et al., Time course of cerebrospinal fluid responses to antiretroviral therapy: evidence for variable compartmentalization of infection, AIDS, 13(9), 1999, pp. 1051-1061
Authors:
Deeks, SG
Hecht, FM
Swanson, M
Elbeik, T
Loftus, R
Cohen, PT
Grant, RM
Citation: Sg. Deeks et al., HIV RNA and CD4 cell count response to protease inhibitor therapy in an urban AIDS clinic: Response to both initial and salvage therapy, AIDS, 13(6), 1999, pp. F35-F43
Authors:
Staprans, SI
Dailey, PJ
Rosenthal, A
Horton, C
Grant, RM
Lerche, N
Feinberg, MB
Citation: Si. Staprans et al., Simian immunodeficiency virus disease course is predicted by the extent ofvirus replication during primary infection, J VIROLOGY, 73(6), 1999, pp. 4829-4839
Authors:
Deeks, SG
Hellmann, NS
Grant, RM
Parkin, NT
Petropoulos, CJ
Becker, M
Symonds, W
Chesney, M
Volberding, PA
Citation: Sg. Deeks et al., Novel four-drug salvage treatment regimens after failure of a human immunodeficiency virus type 1 protease inhibitor-containing regimen: Antiviral activity and correlation of baseline phenotypic drug susceptibility with virologic outcome, J INFEC DIS, 179(6), 1999, pp. 1375-1381
Risultati:
1-22
|